BioCryst (BCRX) Soars 13% on Acquisition Buzz

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) is one of the 10 Stocks Worth Watching Right Now.

BioCryst snapped a three-day losing streak on Monday, jumping 13.14 percent to finish at $9.30 apiece, as investors loaded portfolios amid rumors that it is set to be acquired by a large-cap biopharmaceutical company.

Murmurs about the supposed acquisition broke out on a UK-based website about deals and dealmakers on Monday, saying that a US-based pharmaceutical giant is setting its sights on BioCryst Pharmaceuticals Inc (NASDAQ:BCRX).

As of writing, BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) has yet to confirm or deny the said report.

BioCryst (BCRX) Soars 13% on Acquisition Buzz

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases.

Last month, it announced strong earnings performance in 2025, having swung to a net income of $263.86 million last year from an $88.88 million net loss in 2024. Total revenues soared by 94 percent to $874.8 million from $450.7 million year-on-year, helped by the successful $243.3 million sale of its European Orladeyo business to Neopharmed Gentili. Orladeyo is a prescription oral medicine for preventing hereditary angioedema attacks in adults and children 12 years and older.

In the fourth quarter alone, BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) incurred a $245.8 million net income, reversing a $26.79 million net loss in the same period a year earlier. Total revenues more than tripled to $406.5 million from $131.5 million year-on-year.

While we acknowledge the risk and potential of BCRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BCRX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.